(Q38340264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

Personalised medicine in veterinary oncology: one to cure just one (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

R Klopfleisch

series ordinal

1

1 reference

2 September 2017

8 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

published in

The Veterinary Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

128-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

Genetic variegation of clonal architecture and propagating cells in leukaemia

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

VEGF and MMP-9: biomarkers for canine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Changes in the serum proteome of canine lymphoma identified by electrophoresis and mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The causes and consequences of genetic heterogeneity in cancer evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Genetic instability and darwinian selection in tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Comprehensive genomic characterization of squamous cell lung cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Comprehensive molecular characterization of human colon and rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Comprehensive molecular portraits of human breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The Cancer Genome Atlas Pan-Cancer analysis project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Cancer proteomics by quantitative shotgun proteomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Potential markers for detection of circulating canine mammary tumor cells in the peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Identification of six potential markers for the detection of circulating canine mammary tumour cells in the peripheral blood identified by microarray analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Multiple RT-PCR markers for the detection of circulating tumour cells of metastatic canine mammary tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Proteomic analysis of dog tears for potential cancer markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The history of cancer epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Molecular profiling reveals prognostically significant subtypes of canine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Circulating tumor cells as therapy-related biomarkers in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Genomic landscape of non-small cell lung cancer in smokers and never-smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Masitinib is safe and effective for the treatment of canine mast cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Coping with complexity. multivariate analysis of tumor karyotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The epigenomics of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Comparative lesion sequencing provides insights into tumor evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Personalized oncology: recent advances and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Mutational landscape and significance across 12 major cancer types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Clonal competition with alternating dominance in multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Targeted therapy in older patients with solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Personalized medicine in veterinary oncology: minimal residual disease and circulating tumour cells in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Transcriptome and proteome research in veterinary science: what is possible and what questions can be asked?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Rate, molecular spectrum, and consequences of human mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Parallel evolution of tumour subclones mimics diversity between tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Intra-tumour heterogeneity: a looking glass for cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Proteomics of canine lymphoma identifies potential cancer-specific protein markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Exploring the serum proteome in dogs: setting the scene for the discovery of new biomarkers in canine lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Imatinib responsiveness in canine mast cell tumors carrying novel mutations of c-KIT exon 11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Proteomic identification and profiling of canine lymphoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The prognostic significance of minimal residual disease in the early phases of chemotherapy in dogs with high-grade B-cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

What is personalized medicine: sharpening a vague term based on a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Tandem duplication of KIT exon 11 influences the proteome of canine mast cell tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

The landscape of cancer genes and mutational processes in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Towards a knowledge-based Human Protein Atlas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Technical and implementation issues in using next-generation sequencing of cancers in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Intra-tumor heterogeneity of MLH1 promoter methylation revealed by deep single molecule bisulfite sequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

7 January 2021

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

Masitinib reverses doxorubicin resistance in canine lymphoid cells by inhibiting the function of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2015.01.004

10.1016/J.TVJL.2015.01.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25641551%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference